NO770059L - - Google Patents
Info
- Publication number
- NO770059L NO770059L NO770059A NO770059A NO770059L NO 770059 L NO770059 L NO 770059L NO 770059 A NO770059 A NO 770059A NO 770059 A NO770059 A NO 770059A NO 770059 L NO770059 L NO 770059L
- Authority
- NO
- Norway
- Prior art keywords
- isolating
- lactate
- separating
- glycoproteins
- glycoprotein
- Prior art date
Links
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 15
- 239000002244 precipitate Substances 0.000 claims description 11
- 238000000034 method Methods 0.000 claims description 8
- 239000011780 sodium chloride Substances 0.000 claims description 8
- 210000002966 serum Anatomy 0.000 claims description 7
- 201000010099 disease Diseases 0.000 claims description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 4
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 4
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 4
- 210000002826 placenta Anatomy 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- 210000004369 blood Anatomy 0.000 claims description 3
- 239000008280 blood Substances 0.000 claims description 3
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 102000003886 Glycoproteins Human genes 0.000 claims description 2
- 108090000288 Glycoproteins Proteins 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims description 2
- -1 dimethoxy-acridine lactate Chemical compound 0.000 claims description 2
- 238000013508 migration Methods 0.000 claims description 2
- 230000005012 migration Effects 0.000 claims description 2
- 239000012266 salt solution Substances 0.000 claims description 2
- 238000002560 therapeutic procedure Methods 0.000 claims description 2
- VRQURTHVUQBIMS-UHFFFAOYSA-N 2-acridin-1-yloxyethane-1,1-diamine;2-hydroxypropanoic acid Chemical compound CC(O)C(O)=O.C1=CC=C2C=C3C(OCC(N)N)=CC=CC3=NC2=C1 VRQURTHVUQBIMS-UHFFFAOYSA-N 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- 229920001817 Agar Polymers 0.000 claims 1
- 238000003748 differential diagnosis Methods 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 239000000872 buffer Substances 0.000 description 5
- 238000002955 isolation Methods 0.000 description 4
- 238000007693 zone electrophoresis Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 239000001166 ammonium sulphate Substances 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 108010074605 gamma-Globulins Proteins 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002023 wood Substances 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 241000219112 Cucumis Species 0.000 description 1
- 235000015510 Cucumis melo subsp melo Nutrition 0.000 description 1
- 102100025027 E3 ubiquitin-protein ligase TRIM69 Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 101000830203 Homo sapiens E3 ubiquitin-protein ligase TRIM69 Proteins 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- FJJCIZWZNKZHII-UHFFFAOYSA-N [4,6-bis(cyanoamino)-1,3,5-triazin-2-yl]cyanamide Chemical compound N#CNC1=NC(NC#N)=NC(NC#N)=N1 FJJCIZWZNKZHII-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000003926 acrylamides Chemical class 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000005352 clarification Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
Landscapes
- Peptides Or Proteins (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NO770059A NO770059L (enExample) | 1972-04-29 | 1977-01-07 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19722221261 DE2221261A1 (de) | 1972-04-29 | 1972-04-29 | Ap-glykoproteine und verfahren zu ihrer isolierung |
| NO175873 | 1973-04-27 | ||
| NO770059A NO770059L (enExample) | 1972-04-29 | 1977-01-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO770059L true NO770059L (enExample) | 1973-10-30 |
Family
ID=27184381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO770059A NO770059L (enExample) | 1972-04-29 | 1977-01-07 |
Country Status (1)
| Country | Link |
|---|---|
| NO (1) | NO770059L (enExample) |
-
1977
- 1977-01-07 NO NO770059A patent/NO770059L/no unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wood et al. | The occurrence during acute infections of a protein not normally present in the blood: V. Physical-chemical properties of the C-reactive protein crystallized by a modified technique | |
| MAcLEOD et al. | The occurrence during acute infections of a protein not normally present in the blood: III. Immunological properties of the C-reactive protein and its differentiation from normal blood proteins | |
| Murphy et al. | Five alpha-D-galactopyranosyl-binding isolectins from Bandeiraea simplicifolia seeds. | |
| Jockers-Wretou et al. | Quantitation of creatine kinase isoenzymes in human tissues and sera by an immunological method | |
| Crittenden et al. | Carbohydrate-binding protein 35: identification of the galactose-specific lectin in various tissues of mice | |
| Diaz et al. | Bullous pemphigoid antigen: isolation from normal human skin | |
| Ooi et al. | Classical complement pathway activation in membranoproliferative glomerulonephritis | |
| Beutler et al. | Subunit structure of human hexosaminidase verified: interconvertibility of hexosaminidase isozymes | |
| US4041021A (en) | AP-glycoproteins and process for isolating them | |
| JPH0822876B2 (ja) | ペプチドホルモンカルジオジラチン及びその製造法 | |
| Curtain | The nature of the protein in the hyaluronic complex of bovine synovial fluid | |
| Ling et al. | A component of the medicinal herb ephedra blocks activation in the classical and alternative pathways of complement | |
| DE3425186A1 (de) | Humanproteine, verfahren zu deren herstellung und diese enthaltende testkits | |
| Howe | The influenza virus receptor and blood group antigens of human erythrocyte stroma | |
| Bombardieri et al. | An evaluation of an agar gel diffusion test with crude and purified antigens in the diagnosis of hydatid disease | |
| FI93697B (fi) | Menetelmä trombiinia inhiboivan vaikutuksen omaavan amblyommiinin eristämiseksi | |
| EP0410816B1 (en) | Detection of heparin binding seminal proteins | |
| JPS60215629A (ja) | 組織蛋白質ｐｐ↓２↓１およびその取得法 | |
| Miller et al. | Myosin preparations from the rabbit, rat and mouse | |
| Calvo et al. | Effects of carbamylation of plasma proteins and competitive displacers on drug binding in uremia | |
| KR100379189B1 (ko) | 헬리코박터 파이로리에 의한 위질환 치료제용 조성물 및그 탐색방법 | |
| Brandt et al. | Characterization of the mucopolysaccharides associated with fractions of guanidine-denatured amyloid fibrils | |
| Vesely et al. | Increased release of kaliuretic peptide during immersion-induced central hypervolemia in cirrhotic humans | |
| Pérez-Castillo et al. | Synthesis and release of glucagon by human salivary glands | |
| Matheson et al. | Serologic relationships between β-lysins of different species |